Latest On Apellis Pharmaceuticals, Inc (APLS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-25 17:48 EST | News | Apellis and Sobi to drop ALS candidate on Phase 2 setback | N/A |  |
| 2023-05-18 17:01 EST | News | Apellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition Space | N/A | |
| 2023-05-06 12:27 EST | News | Apellis Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-05-06 12:27 EST | News | Apellis Pharmaceuticals, Inc. (APLS) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-04 22:14 EST | News | Apellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric Bio | N/A | |
| 2023-05-04 22:14 EST | News | Apellis Pharmaceuticals GAAP EPS of -$1.56 misses by $0.10, revenue of $44.84M beats by $18.74M | N/A | |
| 2023-05-03 20:58 EST | News | Apellis Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-05-01 19:14 EST | News | Apellis weakness on Iveric Bio takeout is buying opportunity - analyst | N/A | |
| 2023-05-01 06:55 EST | News | Apellis Pharmaceuticals (APLS) Presents at the Association for Research in Vision and Ophthalmology Annual Meeting - Slideshow | N/A | |
| 2023-04-03 17:26 EST | News | Apellis Pharmaceuticals may be worth $90-$100 a share in sale - analyst | N/A | |
| 2023-04-02 23:22 EST | News | Apellis Pharmaceuticals sees takeover interest from large pharma - Bloomberg | N/A | |
| 2023-03-24 22:48 EST | News | Apellis Pharmaceuticals Is Poised For Dominance In Geographic Atrophy Market | N/A | |
| 2023-03-16 14:19 EST | News | Apellis Pharmaceuticals' Empaveli sNDA action date extended by FDA | N/A | |
| 2023-02-23 11:44 EST | News | Apellis Pharmaceuticals prices $350M in stock offering | N/A | |
| 2023-02-22 09:58 EST | News | Apellis Pharmaceuticals to raise $300M in stock and warrants offering | N/A | |
| 2023-02-21 21:29 EST | News | Apellis Pharmaceuticals GAAP EPS of -$1.50 beats by $0.06, revenue of $22.66M misses by $1.86M | N/A | |
| 2023-02-18 02:43 EST | News | Apellis wins FDA nod for eye disorder therapy | N/A | |
| 2023-01-27 18:43 EST | News | Apellis: Empaveli Ought To Win Approval For Eye Disease In February - The Future Looks Bright | N/A | |
| 2023-01-21 14:26 EST | News | Stocks To Watch: Earnings Heat Up, Healthcare Catalysts And M&A Wildcards | N/A | |
| 2023-01-05 20:02 EST | News | Apellis appoints Baumal as Chief Medical Officer | N/A | |
| 2023-01-04 02:30 EST | News | Apellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech preview | N/A | |
| 2022-12-15 23:44 EST | News | Apellis Pharmaceuticals: Approval Is Baked Into Valuation | N/A | |
| 2022-11-18 10:24 EST | News | Apellis surges 17% as FDA accepts to review new data in filing for eye disorder drug | N/A | |
| 2022-11-11 06:07 EST | News | Apellis, IVERIC bio cut to Hold at Jefferies; says Street overestimates GA market | N/A | |
| 2022-11-08 08:01 EST | News | Apellis Pharmaceuticals GAAP EPS of -$1.75 misses by $0.29, revenue of $22.05M beats by $0.46M | N/A | |
| 2022-11-08 08:00 EST | News | Apellis Pharmaceuticals, Inc. (APLS) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-05 08:22 EST | News | Apellis Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-11-03 23:08 EST | News | Apellis sinks 20% as FDA review period for eye disease drug extends | N/A | |
| 2022-10-16 23:00 EST | News | Citi lists four more value-creating events in biotech for this year | N/A | |
| 2022-09-29 06:33 EST | News | Apellis Pharmaceuticals: Trying To Develop A Blockbuster Franchise | N/A | |
| 2022-09-08 07:22 EST | News | Apellis gains as FDA says AdCom unnecessary for eye disease candidate | N/A | |
| 2022-08-24 16:51 EST | News | Apellis stock dips amid 2-year data of pegcetacoplan for eye disorder | N/A | |
| 2022-08-09 18:37 EST | News | Apellis Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-09 18:37 EST | News | Apellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-08 18:56 EST | News | Apellis Pharmaceuticals GAAP EPS of -$1.46 misses by $0.09, revenue of $16.32M misses by $0.63M | N/A | |
| 2022-08-06 06:05 EST | News | Apellis Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-07-27 15:50 EST | News | Apellis to exchange $75.6M in convertible senior notes for common stock | N/A | |
| 2022-07-20 18:36 EST | News | Apellis Pharmaceuticals: The Meaning Of Priority Review For Pegcetacoplan For Geographic Atrophy | N/A | |
| 2022-07-20 03:57 EST | News | Wainwright sees blockbuster potential for Apellis eye degeneration therapy; shares up 22% | N/A | |
| 2022-07-19 13:21 EST | News | Apellis stock soars 24% as FDA grants priority review to pegcetacoplan for eye disorder | N/A | |
| 2022-07-19 13:19 EST | News | H.C. Wainwright sees blockbuster potential for Apellis' treatment in eye degeneration | N/A | |
| 2022-06-25 15:25 EST | News | Apellis: Mixed Data, But Definitely Approvable In GA | N/A | |
| 2022-06-13 19:55 EST | News | Hot Stocks: APLS & SKIL both gain, TSLA declined despite upgrade, and VLTA plunged | N/A | |
| 2022-06-10 11:34 EST | News | Apellis/Sobi Empaveli shows benefit in rare blood disorder patients in new analyses | N/A | |
| 2022-06-01 11:05 EST | News | Apellis files for FDA approval of pegcetacoplan to treat eye disorder | N/A | |
| 2022-05-06 19:17 EST | News | Apellis Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-06 19:15 EST | News | Apellis Pharmaceuticals (APLS) Investor Presentation - Slideshow | N/A | |
| 2022-05-04 22:43 EST | News | Apellis Pharmaceuticals GAAP EPS of -$1.42 misses by $0.12, revenue of $12.1M misses by $0.52M | N/A | |
| 2022-05-04 22:42 EST | News | Apellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 03:15 EST | News | Apellis Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
About Apellis Pharmaceuticals, Inc (APLS):
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan. The company was incorporated in 2009 and is based in Waltham, Massachusetts.
General
- Name Apellis Pharmaceuticals, Inc
- Symbol APLS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 374
- Fiscal Year EndDecember
- IPO Date2017-11-09
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.apellis.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 13.99
- Price/Book (Most Recent Quarter) 18.33
- Enterprise Value Revenue 12.97
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$6.46
- Next Year EPS Estimate -$5.31
- Next Quarter EPS Estimate -$1.60
- Profit Margin -138%
- Operating Margin -85%
- Return on Assets -20%
- Return on Equity -289%
- Revenue 250.65 million
- Earnings Per Share -$3.32
- Revenue Per Share $3.34
- Gross Profit -74325000
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 3.54 billion
- Analyst Target Price $64.14
- Book Value Per Share $2.69
View More
Share Statistics
- Shares Outstanding 80.38 million
- Shares Float 59.7 million
- % Held by Insiders 2117%
- % Held by Institutions 82.85%
- Shares Short 8.11 million
- Shares Short Prior Month 7.75 million
- Short Ratio 13.44
- Short % of Float 15%
- Short % of Shares Outstanding 10%
View More
Technicals
- Beta 1.52
- 52 Week High $58.47
- 52 Week Low $21.84
- 50 Day Moving Average 46.47
- 200 Day Moving Average 42.62
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Apellis Pharmaceuticals, Inc (APLS) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Apellis Pharmaceuticals, Inc (APLS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | $0.93 | -$0.45 | 304.58% |
| 2020-09-30 | 2020-11-02 | $646000 | -$1.79 | -$1.58 | -13.31% |
| 2020-06-30 | 2020-07-30 | $N/A | -$1.57 | -$1.34 | -17.56% |
| 2020-03-31 | 2020-04-29 | $N/A | -$2.29 | -$1.39 | -64.72% |
| 2019-12-31 | 2020-02-27 | $N/A | -$1.77 | -$1.14 | -55% |
| 2019-09-30 | 2019-11-05 | $N/A | -$1.10 | -$1.03 | -6.44% |
| 2019-06-30 | 2019-07-31 | $N/A | -$1.12 | -$0.78 | -44.39% |
| 2019-03-31 | 2019-05-07 | $N/A | -$0.87 | -$0.68 | -27.49% |
| 2018-12-31 | 2019-02-26 | $N/A | -$0.65 | -$0.70 | 7.58% |
| 2018-09-30 | 2018-11-13 | $N/A | -$0.64 | -$0.69 | 7.02% |
| 2018-06-30 | 2018-07-31 | $N/A | -$0.61 | -$0.42 | -45.86% |
| 2018-03-31 | 2018-04-30 | $N/A | -$0.43 | -$0.27 | -57.28% |
| 2017-12-31 | 2018-03-19 | $N/A | -$0.61 | -$0.27 | -129.32% |
| 2017-09-30 | 2017-12-20 | $N/A | -$0.23 | -$0.24 | 2.75% |
Apellis Pharmaceuticals, Inc (APLS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Apellis Pharmaceuticals, Inc (APLS) Chart:
Apellis Pharmaceuticals, Inc (APLS) News:
Below you will find a list of latest news for Apellis Pharmaceuticals, Inc (APLS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Apellis Pharmaceuticals, Inc (APLS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-08-15 | 10 | 0 | CALL | 0 | 0 | 142.13 | TRUE | 0 | 0 |
| 2025-08-15 | 11 | 0 | CALL | 0 | 0 | 143.51 | TRUE | 0 | 0 |
| 2025-08-15 | 12 | 6.2 | CALL | 0 | 30 | 137.01 | TRUE | 0 | 0 |
| 2025-08-15 | 13 | 0 | CALL | 0 | 0 | 127.32 | TRUE | 0 | 0 |
| 2025-08-15 | 14 | 0 | CALL | 0 | 0 | 108.36 | TRUE | 0 | 0 |
| 2025-08-15 | 15 | 5 | CALL | 5 | 5 | 114.27 | TRUE | 5 | 0 |
| 2025-08-15 | 16 | 3.96 | CALL | 0 | 17 | 107.72 | TRUE | 0 | 0 |
| 2025-08-15 | 17 | 3.72 | CALL | 0 | 1 | 101.5 | TRUE | 0 | 0 |
| 2025-08-15 | 18 | 3 | CALL | 0 | 123 | 107.09 | TRUE | 0 | 0 |
| 2025-08-15 | 19 | 2.3 | CALL | 5 | 471 | 109.56 | TRUE | -0.35 | -0.13 |
| 2025-08-15 | 20 | 1.82 | CALL | 226 | 2449 | 108.4 | FALSE | -0.28 | -0.13 |
| 2025-08-15 | 21 | 1.5 | CALL | 57 | 218 | 111.87 | FALSE | -0.1 | -0.06 |
| 2025-08-15 | 22 | 1.25 | CALL | 140 | 937 | 115.65 | FALSE | -0.1 | -0.07 |
| 2025-08-15 | 23 | 0.96 | CALL | 80 | 175 | 113.91 | FALSE | -0.04 | -0.04 |
| 2025-08-15 | 24 | 0.7 | CALL | 51 | 903 | 110.55 | FALSE | -0.17 | -0.2 |
| 2025-08-15 | 25 | 0.5 | CALL | 60 | 1540 | 107.68 | FALSE | -0.2 | -0.29 |
| 2025-08-15 | 26 | 0.45 | CALL | 45 | 277 | 113.92 | FALSE | 0 | 0 |
| 2025-08-15 | 30 | 0.15 | CALL | 5 | 328 | 113.45 | FALSE | 0 | 0 |
| 2025-08-15 | 35 | 0 | CALL | 0 | 0 | 155.49 | FALSE | 0 | 0 |
| 2025-08-15 | 10 | 0 | PUT | 0 | 0 | 217.42 | FALSE | 0 | 0 |
| 2025-08-15 | 11 | 0.09 | PUT | 0 | 1 | 191.67 | FALSE | 0 | 0 |
| 2025-08-15 | 12 | 0.22 | PUT | 0 | 5 | 155.64 | FALSE | 0 | 0 |
| 2025-08-15 | 13 | 0.08 | PUT | 0 | 12 | 111.3 | FALSE | 0 | 0 |
| 2025-08-15 | 14 | 0.2 | PUT | 60 | 70 | 111.91 | FALSE | 0 | 0 |
| 2025-08-15 | 15 | 0.3 | PUT | 81 | 156 | 106.12 | FALSE | -0.02 | -0.06 |
| 2025-08-15 | 16 | 0.55 | PUT | 103 | 115 | 110.01 | FALSE | 0 | 0 |
| 2025-08-15 | 17 | 0.75 | PUT | 131 | 183 | 103.57 | FALSE | -0.14 | -0.16 |
| 2025-08-15 | 18 | 1.2 | PUT | 37 | 124 | 108.98 | FALSE | 0.05 | 0.04 |
| 2025-08-15 | 19 | 1.65 | PUT | 62 | 173 | 108.57 | FALSE | 1.65 | 0 |
| 2025-08-15 | 20 | 1.95 | PUT | 2 | 378 | 110.53 | TRUE | -0.19 | -0.09 |
| 2025-08-15 | 21 | 2.75 | PUT | 12 | 0 | 105.52 | TRUE | 2.75 | 0 |
| 2025-08-15 | 22 | 0 | PUT | 0 | 0 | 109.13 | TRUE | 0 | 0 |
| 2025-08-15 | 23 | 4.15 | PUT | 0 | 16 | 103.18 | TRUE | 0 | 0 |
| 2025-08-15 | 24 | 0 | PUT | 0 | 0 | 102.74 | TRUE | 0 | 0 |
| 2025-08-15 | 25 | 0 | PUT | 0 | 0 | 106.66 | TRUE | 0 | 0 |
| 2025-08-15 | 26 | 0 | PUT | 0 | 0 | 108.5 | TRUE | 0 | 0 |
| 2025-08-15 | 30 | 0 | PUT | 0 | 0 | 118.79 | TRUE | 0 | 0 |
| 2025-08-15 | 35 | 0 | PUT | 0 | 0 | 202.05 | TRUE | 0 | 0 |
| 2025-09-19 | 11 | 0 | CALL | 0 | 0 | 120.15 | TRUE | 0 | 0 |
| 2025-09-19 | 12 | 0 | CALL | 0 | 0 | 113.55 | TRUE | 0 | 0 |
| 2025-09-19 | 13 | 0 | CALL | 0 | 0 | 90.95 | TRUE | 0 | 0 |
| 2025-09-19 | 14 | 0 | CALL | 0 | 0 | 81.53 | TRUE | 0 | 0 |
| 2025-09-19 | 15 | 5.12 | CALL | 0 | 1 | 77.94 | TRUE | 0 | 0 |
| 2025-09-19 | 16 | 4.5 | CALL | 0 | 5 | 84.19 | TRUE | 0 | 0 |
| 2025-09-19 | 17 | 0 | CALL | 0 | 0 | 75.91 | TRUE | 0 | 0 |
| 2025-09-19 | 18 | 0 | CALL | 0 | 0 | 81.31 | TRUE | 0 | 0 |
| 2025-09-19 | 19 | 2.95 | CALL | 0 | 1 | 78.38 | TRUE | 0 | 0 |
| 2025-09-19 | 20 | 2.19 | CALL | 47 | 17 | 76.44 | FALSE | -0.24 | -0.1 |
| 2025-09-19 | 21 | 1.8 | CALL | 1 | 24 | 76.36 | FALSE | 1.8 | 0 |
| 2025-09-19 | 22 | 1.47 | CALL | 26 | 0 | 76.3 | FALSE | 1.47 | 0 |
| 2025-09-19 | 23 | 1.07 | CALL | 0 | 0 | 79.11 | FALSE | 0 | 0 |
| 2025-09-19 | 24 | 0 | CALL | 0 | 0 | 78.48 | FALSE | 0 | 0 |
| 2025-09-19 | 25 | 0.85 | CALL | 0 | 143 | 77.16 | FALSE | 0 | 0 |
| 2025-09-19 | 26 | 0.59 | CALL | 0 | 1 | 77.43 | FALSE | 0 | 0 |
| 2025-09-19 | 27 | 0.6 | CALL | 0 | 4 | 78.78 | FALSE | 0 | 0 |
| 2025-09-19 | 11 | 0 | PUT | 0 | 0 | 118.78 | FALSE | 0 | 0 |
| 2025-09-19 | 12 | 0 | PUT | 0 | 0 | 106.55 | FALSE | 0 | 0 |
| 2025-09-19 | 13 | 0 | PUT | 0 | 0 | 74.08 | FALSE | 0 | 0 |
| 2025-09-19 | 14 | 0 | PUT | 0 | 0 | 80.13 | FALSE | 0 | 0 |
| 2025-09-19 | 15 | 0.44 | PUT | 0 | 1 | 78.59 | FALSE | 0 | 0 |
| 2025-09-19 | 16 | 0.74 | PUT | 0 | 1 | 78.05 | FALSE | 0 | 0 |
| 2025-09-19 | 17 | 0.97 | PUT | 0 | 8 | 71.71 | FALSE | 0 | 0 |
| 2025-09-19 | 18 | 1.6 | PUT | 0 | 2 | 80.47 | FALSE | 0 | 0 |
| 2025-09-19 | 19 | 1.9 | PUT | 0 | 2 | 78.6 | FALSE | 0 | 0 |
| 2025-09-19 | 20 | 2.25 | PUT | 0 | 10 | 80.42 | TRUE | 0 | 0 |
| 2025-09-19 | 21 | 0 | PUT | 0 | 0 | 79.28 | TRUE | 0 | 0 |
| 2025-09-19 | 22 | 0 | PUT | 0 | 0 | 79.54 | TRUE | 0 | 0 |
| 2025-09-19 | 23 | 0 | PUT | 0 | 0 | 78.87 | TRUE | 0 | 0 |
| 2025-09-19 | 24 | 0 | PUT | 0 | 0 | 76.38 | TRUE | 0 | 0 |
| 2025-09-19 | 25 | 0 | PUT | 0 | 0 | 80 | TRUE | 0 | 0 |
| 2025-09-19 | 26 | 0 | PUT | 0 | 0 | 78.3 | TRUE | 0 | 0 |
| 2025-09-19 | 27 | 0 | PUT | 0 | 0 | 79.72 | TRUE | 0 | 0 |
| 2025-10-17 | 10 | 7.64 | CALL | 0 | 10 | 85.82 | TRUE | 0 | 0 |
| 2025-10-17 | 11 | 8.91 | CALL | 0 | 60 | 85.93 | TRUE | 0 | 0 |
| 2025-10-17 | 12 | 0 | CALL | 0 | 0 | 90.2 | TRUE | 0 | 0 |
| 2025-10-17 | 13 | 7 | CALL | 0 | 4 | 81.31 | TRUE | 0 | 0 |
| 2025-10-17 | 14 | 5.9 | CALL | 0 | 4 | 77.76 | TRUE | 0 | 0 |
| 2025-10-17 | 15 | 4.29 | CALL | 0 | 0 | 61.59 | TRUE | 0 | 0 |
| 2025-10-17 | 16 | 0 | CALL | 0 | 0 | 72.73 | TRUE | 0 | 0 |
| 2025-10-17 | 17 | 3 | CALL | 0 | 17 | 76.94 | TRUE | 0 | 0 |
| 2025-10-17 | 18 | 3.9 | CALL | 0 | 335 | 75.59 | TRUE | 0 | 0 |
| 2025-10-17 | 19 | 3.3 | CALL | 38 | 448 | 72.73 | TRUE | 3.3 | 0 |
| 2025-10-17 | 20 | 2.7 | CALL | 6 | 3347 | 75.26 | FALSE | 2.7 | 0 |
| 2025-10-17 | 21 | 2.7 | CALL | 1 | 42 | 70.88 | FALSE | 2.7 | 0 |
| 2025-10-17 | 22 | 2.2 | CALL | 1 | 48 | 73.21 | FALSE | 2.2 | 0 |
| 2025-10-17 | 23 | 1.65 | CALL | 0 | 77 | 71.57 | FALSE | 0 | 0 |
| 2025-10-17 | 24 | 1.35 | CALL | 0 | 140 | 70.77 | FALSE | 0 | 0 |
| 2025-10-17 | 25 | 1.25 | CALL | 0 | 193 | 71.06 | FALSE | 0 | 0 |
| 2025-10-17 | 26 | 0.9 | CALL | 0 | 6 | 73.59 | FALSE | 0 | 0 |
| 2025-10-17 | 27 | 0.75 | CALL | 1 | 10 | 71.15 | FALSE | 0.75 | 0 |
| 2025-10-17 | 28 | 0.8 | CALL | 0 | 37 | 73.09 | FALSE | 0 | 0 |
| 2025-10-17 | 29 | 0.42 | CALL | 1 | 2 | 66.8 | FALSE | 0.42 | 0 |
| 2025-10-17 | 30 | 0.45 | CALL | 0 | 66 | 64.56 | FALSE | 0 | 0 |
| 2025-10-17 | 31 | 0.43 | CALL | 0 | 59 | 66.63 | FALSE | 0 | 0 |
| 2025-10-17 | 32 | 0 | CALL | 0 | 3 | 68.38 | FALSE | 0 | 0 |
| 2025-10-17 | 33 | 0.4 | CALL | 0 | 29 | 69.83 | FALSE | 0 | 0 |
| 2025-10-17 | 34 | 0 | CALL | 0 | 0 | 69.03 | FALSE | 0 | 0 |
| 2025-10-17 | 35 | 0 | CALL | 0 | 0 | 71.77 | FALSE | 0 | 0 |
| 2025-10-17 | 36 | 0 | CALL | 0 | 5 | 69.81 | FALSE | 0 | 0 |
| 2025-10-17 | 40 | 0 | CALL | 0 | 26 | 93.63 | FALSE | 0 | 0 |
| 2025-10-17 | 10 | 0 | PUT | 0 | 0 | 100.13 | FALSE | 0 | 0 |
| 2025-10-17 | 11 | 0 | PUT | 0 | 0 | 99.13 | FALSE | 0 | 0 |
| 2025-10-17 | 12 | 0.55 | PUT | 0 | 96 | 70.08 | FALSE | 0 | 0 |
| 2025-10-17 | 13 | 0 | PUT | 0 | 17 | 76.07 | FALSE | 0 | 0 |
| 2025-10-17 | 14 | 0.8 | PUT | 0 | 112 | 75.26 | FALSE | 0 | 0 |
| 2025-10-17 | 15 | 0.65 | PUT | 0 | 594 | 63.29 | FALSE | 0 | 0 |
| 2025-10-17 | 16 | 1 | PUT | 0 | 5 | 71.55 | FALSE | 0 | 0 |
| 2025-10-17 | 17 | 1.35 | PUT | 0 | 13 | 71.31 | FALSE | 0 | 0 |
| 2025-10-17 | 18 | 1.85 | PUT | 0 | 371 | 74.34 | FALSE | 0 | 0 |
| 2025-10-17 | 19 | 2.3 | PUT | 0 | 273 | 71.73 | FALSE | 0 | 0 |
| 2025-10-17 | 20 | 2.7 | PUT | 0 | 330 | 74.45 | TRUE | 0 | 0 |
| 2025-10-17 | 21 | 0 | PUT | 0 | 15 | 74.25 | TRUE | 0 | 0 |
| 2025-10-17 | 22 | 4.73 | PUT | 0 | 54 | 74.02 | TRUE | 0 | 0 |
| 2025-10-17 | 23 | 0 | PUT | 0 | 2 | 72.49 | TRUE | 0 | 0 |
| 2025-10-17 | 24 | 0 | PUT | 0 | 2 | 75.45 | TRUE | 0 | 0 |
| 2025-10-17 | 25 | 0 | PUT | 0 | 65 | 74.52 | TRUE | 0 | 0 |
| 2025-10-17 | 26 | 0 | PUT | 0 | 4 | 72.4 | TRUE | 0 | 0 |
| 2025-10-17 | 27 | 0 | PUT | 0 | 3 | 76.02 | TRUE | 0 | 0 |
| 2025-10-17 | 28 | 0 | PUT | 0 | 0 | 73.56 | TRUE | 0 | 0 |
| 2025-10-17 | 29 | 0 | PUT | 0 | 0 | 73.94 | TRUE | 0 | 0 |
| 2025-10-17 | 30 | 0 | PUT | 0 | 0 | 65.13 | TRUE | 0 | 0 |
| 2025-10-17 | 31 | 0 | PUT | 0 | 0 | 74.76 | TRUE | 0 | 0 |
| 2025-10-17 | 32 | 0 | PUT | 0 | 0 | 81.09 | TRUE | 0 | 0 |
| 2025-10-17 | 33 | 0 | PUT | 0 | 0 | 71.91 | TRUE | 0 | 0 |
| 2025-10-17 | 34 | 0 | PUT | 0 | 0 | 79.02 | TRUE | 0 | 0 |
| 2025-10-17 | 35 | 0 | PUT | 0 | 0 | 72.99 | TRUE | 0 | 0 |
| 2025-10-17 | 36 | 0 | PUT | 0 | 0 | 99.75 | TRUE | 0 | 0 |
| 2025-10-17 | 40 | 0 | PUT | 0 | 0 | 96.34 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 0 | CALL | 0 | 0 | 89.86 | TRUE | 0 | 0 |
| 2026-01-16 | 11 | 0 | CALL | 0 | 0 | 76.42 | TRUE | 0 | 0 |
| 2026-01-16 | 12 | 0 | CALL | 0 | 0 | 79.06 | TRUE | 0 | 0 |
| 2026-01-16 | 13 | 0 | CALL | 0 | 8 | 69.11 | TRUE | 0 | 0 |
| 2026-01-16 | 14 | 0 | CALL | 0 | 0 | 58.23 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 7 | CALL | 0 | 40 | 70.71 | TRUE | 0 | 0 |
| 2026-01-16 | 16 | 5 | CALL | 0 | 2 | 71.83 | TRUE | 0 | 0 |
| 2026-01-16 | 17 | 3.9 | CALL | 0 | 60 | 71.71 | TRUE | 0 | 0 |
| 2026-01-16 | 18 | 4.55 | CALL | 0 | 147 | 72.71 | TRUE | 0 | 0 |
| 2026-01-16 | 19 | 4.3 | CALL | 3 | 8 | 72.76 | TRUE | 4.3 | 0 |
| 2026-01-16 | 20 | 3.63 | CALL | 0 | 10076 | 70.13 | FALSE | 0 | 0 |
| 2026-01-16 | 21 | 3.51 | CALL | 0 | 126 | 71.57 | FALSE | 0 | 0 |
| 2026-01-16 | 22.5 | 2.9 | CALL | 0 | 40 | 69.68 | FALSE | 0 | 0 |
| 2026-01-16 | 24 | 2.45 | CALL | 1 | 100 | 70.17 | FALSE | 2.45 | 0 |
| 2026-01-16 | 25 | 2.18 | CALL | 0 | 94 | 68.73 | FALSE | 0 | 0 |
| 2026-01-16 | 26 | 1.9 | CALL | 0 | 1 | 68.2 | FALSE | 0 | 0 |
| 2026-01-16 | 30 | 1.25 | CALL | 0 | 1524 | 68.22 | FALSE | 0 | 0 |
| 2026-01-16 | 35 | 0.6 | CALL | 0 | 1231 | 67.05 | FALSE | 0 | 0 |
| 2026-01-16 | 40 | 0.5 | CALL | 0 | 10399 | 67.19 | FALSE | 0 | 0 |
| 2026-01-16 | 45 | 0.2 | CALL | 200 | 465 | 66.14 | FALSE | 0.2 | 0 |
| 2026-01-16 | 50 | 0.25 | CALL | 0 | 391 | 74.02 | FALSE | 0 | 0 |
| 2026-01-16 | 55 | 0 | CALL | 0 | 389 | 82.63 | FALSE | 0 | 0 |
| 2026-01-16 | 60 | 0.05 | CALL | 105 | 1077 | 67.84 | FALSE | 0.05 | 0 |
| 2026-01-16 | 65 | 0.15 | CALL | 0 | 400 | 89.26 | FALSE | 0 | 0 |
| 2026-01-16 | 70 | 0 | CALL | 0 | 348 | 91.62 | FALSE | 0 | 0 |
| 2026-01-16 | 75 | 0 | CALL | 0 | 139 | 95.38 | FALSE | 0 | 0 |
| 2026-01-16 | 80 | 0 | CALL | 0 | 186 | 86.08 | FALSE | 0 | 0 |
| 2026-01-16 | 85 | 0 | CALL | 0 | 637 | 102.08 | FALSE | 0 | 0 |
| 2026-01-16 | 90 | 0 | CALL | 0 | 84 | 124.94 | FALSE | 0 | 0 |
| 2026-01-16 | 95 | 0 | CALL | 0 | 24 | 107.91 | FALSE | 0 | 0 |
| 2026-01-16 | 100 | 0 | CALL | 0 | 27 | 127.42 | FALSE | 0 | 0 |
| 2026-01-16 | 105 | 0 | CALL | 0 | 96 | 126.24 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 0 | PUT | 0 | 12 | 70.04 | FALSE | 0 | 0 |
| 2026-01-16 | 11 | 0 | PUT | 0 | 0 | 75.95 | FALSE | 0 | 0 |
| 2026-01-16 | 12 | 0 | PUT | 0 | 5 | 74.51 | FALSE | 0 | 0 |
| 2026-01-16 | 13 | 0 | PUT | 0 | 100 | 71.88 | FALSE | 0 | 0 |
| 2026-01-16 | 14 | 1.05 | PUT | 0 | 6 | 72.92 | FALSE | 0 | 0 |
| 2026-01-16 | 15 | 2.42 | PUT | 0 | 119 | 71.75 | FALSE | 0 | 0 |
| 2026-01-16 | 16 | 0 | PUT | 0 | 0 | 70.8 | FALSE | 0 | 0 |
| 2026-01-16 | 17 | 2.2 | PUT | 0 | 80 | 72.74 | FALSE | 0 | 0 |
| 2026-01-16 | 18 | 2.85 | PUT | 0 | 7 | 71.42 | FALSE | 0 | 0 |
| 2026-01-16 | 19 | 3.3 | PUT | 0 | 7 | 71.81 | FALSE | 0 | 0 |
| 2026-01-16 | 20 | 3.5 | PUT | 0 | 709 | 71.37 | TRUE | 0 | 0 |
| 2026-01-16 | 21 | 5.5 | PUT | 0 | 1 | 70.21 | TRUE | 0 | 0 |
| 2026-01-16 | 22.5 | 5.4 | PUT | 0 | 566 | 70.49 | TRUE | 0 | 0 |
| 2026-01-16 | 24 | 0 | PUT | 0 | 25 | 69.37 | TRUE | 0 | 0 |
| 2026-01-16 | 25 | 6.7 | PUT | 0 | 152 | 69.49 | TRUE | 0 | 0 |
| 2026-01-16 | 26 | 0 | PUT | 0 | 0 | 69.08 | TRUE | 0 | 0 |
| 2026-01-16 | 30 | 10.69 | PUT | 0 | 1237 | 67.67 | TRUE | 0 | 0 |
| 2026-01-16 | 35 | 0 | PUT | 0 | 731 | 72.09 | TRUE | 0 | 0 |
| 2026-01-16 | 40 | 0 | PUT | 0 | 1 | 88.14 | TRUE | 0 | 0 |
| 2026-01-16 | 45 | 0 | PUT | 0 | 0 | 99.54 | TRUE | 0 | 0 |
| 2026-01-16 | 50 | 0 | PUT | 0 | 12 | 93.5 | TRUE | 0 | 0 |
| 2026-01-16 | 55 | 0 | PUT | 0 | 23 | 112.79 | TRUE | 0 | 0 |
| 2026-01-16 | 60 | 0 | PUT | 0 | 0 | 142.18 | TRUE | 0 | 0 |
| 2026-01-16 | 65 | 0 | PUT | 0 | 337 | 126.09 | TRUE | 0 | 0 |
| 2026-01-16 | 70 | 0 | PUT | 0 | 1163 | 135.33 | TRUE | 0 | 0 |
| 2026-01-16 | 75 | 0 | PUT | 0 | 0 | 140.8 | TRUE | 0 | 0 |
| 2026-01-16 | 80 | 0 | PUT | 0 | 0 | 142.42 | TRUE | 0 | 0 |
| 2026-01-16 | 85 | 0 | PUT | 0 | 0 | 134.29 | TRUE | 0 | 0 |
| 2026-01-16 | 90 | 0 | PUT | 0 | 0 | 127.99 | TRUE | 0 | 0 |
| 2026-01-16 | 95 | 0 | PUT | 0 | 0 | 150.07 | TRUE | 0 | 0 |
| 2026-01-16 | 100 | 0 | PUT | 0 | 0 | 135.95 | TRUE | 0 | 0 |
| 2026-01-16 | 105 | 0 | PUT | 0 | 0 | 157.82 | TRUE | 0 | 0 |
| 2027-01-15 | 5 | 15.1 | CALL | 0 | 4 | 60.55 | TRUE | 0 | 0 |
| 2027-01-15 | 10 | 11.3 | CALL | 0 | 18 | 55.6 | TRUE | 0 | 0 |
| 2027-01-15 | 15 | 7.88 | CALL | 200 | 239 | 65.46 | TRUE | 7.88 | 0 |
| 2027-01-15 | 20 | 5.9 | CALL | 0 | 98 | 61.73 | FALSE | 0 | 0 |
| 2027-01-15 | 23 | 0 | CALL | 0 | 28 | 61.25 | FALSE | 0 | 0 |
| 2027-01-15 | 25 | 4.5 | CALL | 0 | 42 | 60.08 | FALSE | 0 | 0 |
| 2027-01-15 | 28 | 0 | CALL | 0 | 4 | 57.32 | FALSE | 0 | 0 |
| 2027-01-15 | 30 | 2.47 | CALL | 0 | 134 | 57.7 | FALSE | 0 | 0 |
| 2027-01-15 | 33 | 2.37 | CALL | 0 | 5 | 57.03 | FALSE | 0 | 0 |
| 2027-01-15 | 35 | 2.4 | CALL | 0 | 35 | 53.84 | FALSE | 0 | 0 |
| 2027-01-15 | 37 | 0 | CALL | 0 | 0 | 55.72 | FALSE | 0 | 0 |
| 2027-01-15 | 40 | 1.3 | CALL | 0 | 67 | 55.39 | FALSE | 0 | 0 |
| 2027-01-15 | 42 | 0 | CALL | 0 | 2736 | 55.3 | FALSE | 0 | 0 |
| 2027-01-15 | 45 | 0.85 | CALL | 0 | 34 | 54.41 | FALSE | 0 | 0 |
| 2027-01-15 | 47 | 0 | CALL | 0 | 0 | 64.27 | FALSE | 0 | 0 |
| 2027-01-15 | 50 | 0 | CALL | 0 | 36 | 60.32 | FALSE | 0 | 0 |
| 2027-01-15 | 55 | 0.55 | CALL | 0 | 420 | 49.79 | FALSE | 0 | 0 |
| 2027-01-15 | 5 | 0 | PUT | 0 | 0 | 185.12 | FALSE | 0 | 0 |
| 2027-01-15 | 10 | 0 | PUT | 0 | 0 | 77.58 | FALSE | 0 | 0 |
| 2027-01-15 | 15 | 2.85 | PUT | 0 | 349 | 59.36 | FALSE | 0 | 0 |
| 2027-01-15 | 20 | 5.38 | PUT | 200 | 255 | 61.64 | TRUE | 5.38 | 0 |
| 2027-01-15 | 23 | 0 | PUT | 0 | 2 | 60.86 | TRUE | 0 | 0 |
| 2027-01-15 | 25 | 8.8 | PUT | 1 | 367 | 62.44 | TRUE | 8.8 | 0 |
| 2027-01-15 | 28 | 0 | PUT | 0 | 0 | 59.27 | TRUE | 0 | 0 |
| 2027-01-15 | 30 | 12.81 | PUT | 0 | 11 | 58.38 | TRUE | 0 | 0 |
| 2027-01-15 | 33 | 16.37 | PUT | 0 | 5 | 58.03 | TRUE | 0 | 0 |
| 2027-01-15 | 35 | 16.12 | PUT | 0 | 3 | 57.81 | TRUE | 0 | 0 |
| 2027-01-15 | 37 | 0 | PUT | 0 | 0 | 57.66 | TRUE | 0 | 0 |
| 2027-01-15 | 40 | 0 | PUT | 0 | 0 | 69.67 | TRUE | 0 | 0 |
| 2027-01-15 | 42 | 0 | PUT | 0 | 2 | 58.26 | TRUE | 0 | 0 |
| 2027-01-15 | 45 | 0 | PUT | 0 | 0 | 59.93 | TRUE | 0 | 0 |
| 2027-01-15 | 47 | 0 | PUT | 0 | 0 | 70.54 | TRUE | 0 | 0 |
| 2027-01-15 | 50 | 0 | PUT | 0 | 0 | 79.91 | TRUE | 0 | 0 |
| 2027-01-15 | 55 | 0 | PUT | 0 | 0 | 64.42 | TRUE | 0 | 0 |
Latest APLS Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 5 | $39.4 |
| Jun 13, 2022 7:59 PM EST | 25 | $39.4 |
| Jun 13, 2022 7:59 PM EST | 86 | $39.39 |
| Jun 13, 2022 7:59 PM EST | 14 | $39.4 |
| Jun 13, 2022 7:59 PM EST | 32 | $39.4 |
Apellis Pharmaceuticals, Inc (APLS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1492422/000083423720004741/0000834237-20-004741-index.htm |
| 2020-02-05 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320003295/0000899243-20-003295-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320008068/0000899243-20-008068-index.htm |
| 2020-10-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320027595/0000899243-20-027595-index.htm |
| 2020-10-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000089924320027598/0000899243-20-027598-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1492422/000090221920000352/0000902219-20-000352-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1492422/000090266420001196/0000902664-20-001196-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1492422/000092963820000336/0000929638-20-000336-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm |
| 2020-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm |
| 2020-04-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220013334/0001127602-20-013334-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220013338/0001127602-20-013338-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm |
| 2020-04-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220014554/0001127602-20-014554-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm |
| 2020-06-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220019258/0001127602-20-019258-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm |
| 2020-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm |
| 2020-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm |
| 2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm |
| 2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm |
| 2020-02-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1492422/000119312520052855/0001193125-20-052855-index.htm |
| 2020-02-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1492422/000119312520052867/0001193125-20-052867-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1492422/000119312520098977/0001193125-20-098977-index.htm |
| 2020-04-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1492422/000119312520115068/0001193125-20-115068-index.htm |
| 2020-04-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1492422/000119312520115084/0001193125-20-115084-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1492422/000119312520135621/0001193125-20-135621-index.htm |
| 2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1492422/000119312520141579/0001193125-20-141579-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1492422/000119312520157384/0001193125-20-157384-index.htm |
| 2020-10-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1492422/000119312520277496/0001193125-20-277496-index.htm |
| 2010-05-19 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1492242/000149224210000001/0001492242-10-000001-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1492422/000156459020007350/0001564590-20-007350-index.htm |
| 2020-04-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1492422/000156459020019689/0001564590-20-019689-index.htm |
| 2020-07-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1492422/000156459020034763/0001564590-20-034763-index.htm |
| 2020-11-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1492422/000156459020049423/0001564590-20-049423-index.htm |
| 2020-08-24 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1492422/999999999720004458/9999999997-20-004458-index.htm |
Apellis Pharmaceuticals, Inc (APLS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc (APLS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2117%Institutional Ownership: 8285%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-02-13 | Pascal Deschatelets | Chief Operating Officer | Sell | 55,398.00 | 40.98 | 2,270,154.64 | 1,008,681.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm |
| 2020-02-18 | Cedric Francois | Chief Executive Officer | Sell | 5,000.00 | 40.67 | 203,330.00 | 1,027,430.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm |
| 2020-02-18 | Cedric Francois | Chief Executive Officer | Sell | 30,637.00 | 40.66 | 1,245,792.33 | 1,032,430.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm |
| 2020-03-16 | Cedric Francois | Chief Executive Officer | Sell | 300.00 | 23.86 | 7,158.00 | 1,053,067.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm |
| 2020-03-16 | Cedric Francois | Chief Executive Officer | Sell | 3,212.00 | 22.28 | 71,556.94 | 1,053,367.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm |
| 2020-03-16 | Cedric Francois | Chief Executive Officer | Sell | 15,065.00 | 21.58 | 325,087.64 | 1,056,579.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm |
| 2020-02-19 | Cedric Francois | Chief Executive Officer | Buy | 30,637.00 | 2.14 | 65,563.18 | 1,058,067.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm |
| 2020-02-18 | Cedric Francois | Chief Executive Officer | Buy | 30,637.00 | 2.14 | 65,563.18 | 1,063,067.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm |
| 2020-02-13 | Pascal Deschatelets | Chief Operating Officer | Buy | 117,205.00 | 2.14 | 250,818.70 | 1,064,079.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm |
| 2020-02-10 | Cedric Francois | Chief Executive Officer | Buy | 34,375.00 | 1,066,805.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm | ||
| 2020-03-16 | Cedric Francois | Chief Executive Officer | Sell | 12,060.00 | 20.69 | 249,557.58 | 1,071,644.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm |
| 2020-10-15 | Cedric Francois | Chief Executive Officer | Sell | 5,000.00 | 34.46 | 172,300.00 | 1,083,079.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm |
| 2020-03-17 | Cedric Francois | Chief Executive Officer | Buy | 30,637.00 | 2.14 | 65,563.18 | 1,083,704.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm |
| 2020-03-16 | Cedric Francois | Chief Executive Officer | Sell | 700.00 | 22.29 | 15,600.20 | 1,083,704.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm |
| 2020-03-16 | Cedric Francois | Chief Executive Officer | Sell | 2,192.00 | 21.57 | 47,279.25 | 1,084,404.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm |
| 2020-03-16 | Cedric Francois | Chief Executive Officer | Sell | 2,108.00 | 20.73 | 43,694.62 | 1,086,596.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm |
| 2020-09-15 | Cedric Francois | Chief Executive Officer | Sell | 5,000.00 | 30.96 | 154,800.00 | 1,088,079.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm |
| 2020-03-16 | Cedric Francois | Chief Executive Officer | Buy | 30,637.00 | 2.14 | 65,563.18 | 1,088,704.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm |
| 2020-08-20 | Cedric Francois | Chief Executive Officer | Sell | 3,457.00 | 30.00 | 103,710.00 | 1,093,079.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm |
| 2020-08-18 | Cedric Francois | Chief Executive Officer | Sell | 1,543.00 | 30.00 | 46,290.00 | 1,096,536.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm |
| 2020-07-15 | Cedric Francois | Chief Executive Officer | Sell | 5,000.00 | 32.12 | 160,600.00 | 1,098,079.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm |
| 2020-06-15 | Cedric Francois | Chief Executive Officer | Sell | 5,000.00 | 30.21 | 151,050.00 | 1,103,079.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm |
| 2020-05-15 | Cedric Francois | Chief Executive Officer | Sell | 5,000.00 | 29.92 | 149,600.00 | 1,108,079.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm |
| 2020-04-15 | Cedric Francois | Chief Executive Officer | Sell | 5,000.00 | 29.77 | 148,850.00 | 1,113,079.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm |
| 2020-02-10 | LUKAS SCHEIBLER | Officer | Buy | 9,375.00 | 12,310.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm | ||
| 2020-10-07 | Victoria L. Brown | Program Team Lead | Buy | 12,000.00 | 18.98 | 227,760.00 | 15,607.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm |
| 2020-02-10 | Timothy Eugene Sullivan | Chief Financial Officer | Buy | 11,688.00 | 23,387.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm | ||
| 2020-02-10 | Nicole D Perry | Vice President - Finance | Buy | 2,500.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm | ||
| 2020-02-10 | Ahmad Sadr | Officer | Buy | 2,725.00 | 2,725.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm | ||
| 2020-11-02 | Federico Grossi | CHIEF MEDICAL OFFICER | Sell | 600.00 | 31.09 | 18,654.00 | 27,725.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm |
| 2020-10-01 | Federico Grossi | Officer | Sell | 600.00 | 30.22 | 18,132.00 | 28,325.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm |
| 2020-09-01 | Federico Grossi | Officer | Sell | 600.00 | 31.58 | 18,948.00 | 28,925.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm |
| 2020-08-03 | Federico Grossi | Officer | Sell | 600.00 | 26.28 | 15,768.00 | 29,525.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm |
| 2020-07-01 | Federico Grossi | Officer | Sell | 850.00 | 32.43 | 27,565.50 | 30,125.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm |
| 2020-06-15 | Federico Grossi | Officer | Sell | 856.00 | 30.21 | 25,859.76 | 30,975.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm |
| 2020-02-10 | Federico Grossi | Officer | Buy | 9,375.00 | 31,831.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm | ||
| 2020-02-10 | David O. Watson | General Counsel | Sell | 5,000.00 | 44.50 | 222,500.00 | 35,417.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm |
| 2020-10-07 | Victoria L. Brown | Program Team Lead | Sell | 12,000.00 | 35.00 | 420,000.00 | 3,607.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm |
| 2020-02-10 | David O. Watson | General Counsel | Buy | 6,375.00 | 40,417.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm | ||
| 2020-02-10 | David O. Watson | General Counsel | Buy | 7,505.00 | 2.67 | 20,038.35 | 42,922.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm |
| 2020-05-08 | PAUL R. FONTEYNE | Director | Buy | 5,000.00 | 31.81 | 159,034.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm |
| 2020-02-10 | Lucia Celona | Officer | Buy | 5,213.00 | 5,213.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm | ||
| 2020-02-14 | Alec Machiels | Director | Sell | 2,500.00 | 42.35 | 105,875.00 | 669,544.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm |
| 2020-03-25 | Alec Machiels | Director | Sell | 2,500.00 | 30.00 | 75,000.00 | 669,544.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm |
| 2020-04-15 | Alec Machiels | Director | Sell | 2,500.00 | 30.00 | 75,000.00 | 669,544.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm |
| 2020-05-15 | Alec Machiels | Director | Sell | 2,500.00 | 30.00 | 75,000.00 | 669,544.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm |
| 2020-06-15 | Alec Machiels | Director | Sell | 2,500.00 | 30.21 | 75,525.00 | 669,544.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm |
| 2020-10-07 | Alec Machiels | Director | Sell | 7,500.00 | 35.00 | 262,500.00 | 669,544.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm |
| 2020-10-15 | Alec Machiels | Director | Sell | 2,500.00 | 35.00 | 87,500.00 | 669,544.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm |
| 2020-02-14 | Alec Machiels | Director | Buy | 2,500.00 | 2.67 | 6,675.00 | 672,044.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm |
| 2020-03-25 | Alec Machiels | Director | Buy | 2,500.00 | 2.67 | 6,675.00 | 672,044.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm |
| 2020-04-15 | Alec Machiels | Director | Buy | 2,500.00 | 2.67 | 6,675.00 | 672,044.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm |
| 2020-05-15 | Alec Machiels | Director | Buy | 2,500.00 | 2.67 | 6,675.00 | 672,044.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm |
| 2020-06-15 | Alec Machiels | Director | Buy | 2,500.00 | 2.67 | 6,675.00 | 672,044.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm |
| 2020-10-15 | Alec Machiels | Director | Buy | 2,500.00 | 2.67 | 6,675.00 | 672,044.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm |
| 2020-10-07 | Alec Machiels | Director | Buy | 7,500.00 | 2.67 | 20,025.00 | 677,044.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm |
| 2020-02-10 | Thomas A. Lackner | Officer | Buy | 2,725.00 | 7,725.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm | ||
| 2020-02-10 | Pascal Deschatelets | Chief Operating Officer | Buy | 9,375.00 | 891,118.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm | ||
| 2020-02-10 | Adam J. Townsend | Officer | Buy | 9,375.00 | 9,375.00 | https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm | ||
| 2020-02-12 | Pascal Deschatelets | Chief Operating Officer | Sell | 52,075.00 | 42.80 | 2,228,966.23 | 946,874.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm |
| 2020-02-12 | Pascal Deschatelets | Chief Operating Officer | Buy | 117,206.00 | 2.14 | 250,820.84 | 998,949.00 | https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm |